← Home
🚀 Sign up Free for Company Insights & Valuation!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free
Hikma Pharmaceuticals
-4.0%
Pharma / Pharmaceuticals and Generic Medicines
At a Glance | Core Facts | Company Due Diligence | Industry Due Diligence | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebFinancial Ratios
Pay attention and research significant changes from year to year values. [ ! ]
| Fixed Column | Current Ratio | Quick Ratio | Cash Ratio | Days Of Sales Outstanding | Days Of Inventory Outstanding | Operating Cycle | Days Of Payables Outstanding | Cash Conversion Cycle | Gross Profit Margin | Operating Profit Margin | Pretax Profit Margin | Net Profit Margin | Effective Tax Rate | Return On Assets | Return On Equity | Return On Capital Employed | Net Income Per EBT | EBT Per EBIT | EBIT Per Revenue | Debt Ratio | Debt/Equity Ratio | Long Term Debt To Capitalization | Total Debt To Capitalization | Interest Coverage | Cash Flow To Debt Ratio | Company Equity Multiplier | Receivables Turnover | Payables Turnover | Inventory Turnover | Fixed Asset Turnover | Asset Turnover | Operating Cash Flow Per Share | Free Cash Flow Per Share | Cash Per Share | Payout Ratio | Operating Cash Flow / Sales Ratio | Free Cash Flow / Operating Cash Flow Ratio | Cash Flow Coverage Ratio | Short Term Coverage Ratios | Capital Expenditure Coverage Ratio | Dividend Paid And CAPEX Coverage Ratio | Dividend Payout Ratio | Price Book Value Ratio | Price To Book Ratio | Price To Sales Ratio | Price Earnings Ratio | Price To Free Cash Flows Ratio | Price To Operating Cash Flows Ratio | Price Cash Flow Ratio | Price Earnings To Growth Ratio | Price Sales Ratio | Dividend Yield | Enterprise Value Multiple | Price Fair Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12 | 1.57 | 0.9 | 0.15 | 100.17 | 221.54 | 321.7 | 76.83 | 244.88 | 0.49 | 0.13 | 0.1 | 0.07 | 0.32 | 0.04 | 0.09 | 0.11 | 0.68 | 0.77 | 0.13 | 0.25 | 0.54 | 0.31 | 0.35 | 4.08 | 0.51 | 2.13 | 3.64 | 4.75 | 1.65 | 2.52 | 0.61 | 2.72 | 1.96 | 1.02 | 0.72 | 0.21 | 0.72 | 0.51 | 4.05 | 3.6 | 1.99 | 0.72 | 2.32 | 2.32 | 1.77 | 26.79 | 11.6 | 8.37 | 8.37 | 22.51 | 1.77 | 0.03 | 7.68 | 2.32 |
| 2022-12 | 1.86 | 1.14 | 0.25 | 112.68 | 226.23 | 338.91 | 84.84 | 254.07 | 0.5 | 0.23 | 0.09 | 0.07 | 0.18 | 0.04 | 0.09 | 0.17 | 0.81 | 0.39 | 0.23 | 0.29 | 0.6 | 0.33 | 0.38 | 7.68 | 0.41 | 2.09 | 3.24 | 4.3 | 1.61 | 2.33 | 0.56 | 2.37 | 1.75 | 1.31 | 0.66 | 0.21 | 0.74 | 0.41 | 3.81 | 3.84 | 2.02 | 0.66 | 1.97 | 1.97 | 1.67 | 22.32 | 10.71 | 7.92 | 7.92 | -0.41 | 1.67 | 0.03 | 10.74 | 1.97 |
| 2021-12 | 2.06 | 1.38 | 0.42 | 111.66 | 202.62 | 314.27 | 76.38 | 237.89 | 0.51 | 0.25 | 0.21 | 0.16 | 0.23 | 0.1 | 0.17 | 0.19 | 0.77 | 0.86 | 0.25 | 0.19 | 0.34 | 0.21 | 0.26 | 11.32 | 0.75 | 1.78 | 3.27 | 4.78 | 1.8 | 2.23 | 0.58 | 2.76 | 2.13 | 1.95 | 0.29 | 0.25 | 0.77 | 0.75 | 5.7 | 4.4 | 2.41 | 0.29 | 2.83 | 2.83 | 2.72 | 16.48 | 14.07 | 10.87 | 10.87 | -30.15 | 2.72 | 0.02 | 9.89 | 2.83 |
| 2020-12 | 1.87 | 1.13 | 0.31 | 103.22 | 244.95 | 348.17 | 90.28 | 257.89 | 0.52 | 0.23 | 0.24 | 0.18 | 0.23 | 0.1 | 0.2 | 0.17 | 0.77 | 1.03 | 0.23 | 0.23 | 0.44 | 0.24 | 0.3 | 9.64 | 0.5 | 1.94 | 3.54 | 4.04 | 1.49 | 2.19 | 0.57 | 1.97 | 1.24 | 1.47 | 0.25 | 0.2 | 0.63 | 0.5 | 2.94 | 2.7 | 1.65 | 0.25 | 3.8 | 3.8 | 3.47 | 18.83 | 27.79 | 17.49 | 17.49 | -2.1 | 3.47 | 0.01 | 13.34 | 3.8 |
Wait! There's more — sign up for free or log in